08.05.2014 Views

Speculum - University of Melbourne

Speculum - University of Melbourne

Speculum - University of Melbourne

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

48 SPECULUM<br />

ReJearch . . .<br />

". . . . to merit and preserve the<br />

confidence <strong>of</strong> the best element<br />

in the medical and pharmaceutical<br />

pr<strong>of</strong>essions . . . . to build<br />

well, to last."<br />

It was in these words that, over 90 years ago, the<br />

founders <strong>of</strong> the House <strong>of</strong> Parke-Davis expressed their<br />

policy for the future.<br />

To meet these self-imposed and exacting demands,<br />

research has been a constant feature <strong>of</strong> the Company's<br />

activities. Over the years many contributions to Medicine<br />

have resulted: vegetable drugs such as Cascara<br />

Sagrada; glandular products, including Adrenalin, Pituitrin,<br />

Pitocin, Pitressin, Antuitrin "S" and Eschatin; vitamin<br />

preparations; and many synthetic chemicals such<br />

as Dilantin. Recent achievements include the antihistamines,<br />

Benadryl and Ambodryl, and the first synthetic<br />

antibiotic, Chloromycetin.<br />

Today, backed by a research programme more extensive<br />

than ever before, Parke-Davis <strong>of</strong>fer the medical pr<strong>of</strong>ession<br />

products worthy <strong>of</strong> their symbol, "Medicamenta<br />

Vera"—truth in medicine.<br />

PARKE, DAVIS & CO., LTD.<br />

(Lnc.<br />

BOX 4198, SYDNEY

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!